Physician profile
Susan Cha
NPI 1346360146
$16,560.96
in general payments reported to CMS, 2019-2025
7 companies · $14K in 2025
The $14K reported for 2025 was more than what 97% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21.19 · 2022: $37.59 · 2023: $2,299 · 2024: $88.29 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Travel and Lodging: $4,514 · Food and Beverage: $580.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,408.00 |
| Travel and Lodging | $4,513.77 |
| Food and Beverage | $580.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $14,104.07 | 2022-2025 | |
| Telix Pharmaceuticals | $2,202.75 | 2023-2024 | Illuccix |
| Novartis Pharmaceuticals Corporation | $127.80 | 2023 | |
| Progenics Pharmaceuticals, INC. | $60.30 | 2024-2025 | |
| Sobi, INC | $23.30 | 2022 | |
| Siemens Medical Solutions USA, INC. | $21.55 | 2024 | Posluma |
| Advanced Accelerator Applications | $21.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Cha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.